Healthcare -
Biotechnology - NASDAQ - US
$ 17.06
-3.62 %
$ 1.17 B
Market Cap
-6.16
P/E
ARVN - CASH & EQUIVALENTS
Cash & Equivalents ARVN - Arvinas, Inc.
100 M
LAST VALUE
11.18%
2 YEAR CAGR
61.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR